Clinical Trials Browser

OTHER × sapanisertib × Genitourinary × Clear all

NCT03097328 2024-04-29

Study of TAK-228 In Patients With Previously Treated Metastatic Renal Cell Carcinoma

Phase 2 Completed

39 enrolled 12 charts

Carcinoma, Renal Cell

NCT02091531 2019-11-21

Dual mTOR Inhibitor MLN0128 in Advanced Castration-Resistant Prostate Cancer (CRPC) Patients

Phase 2 Completed

9 enrolled 10 charts

Metastatic Castration-Resistant Prostate Cancer

NCT03745911 2018-11-19

Paclitaxel and TAK-228 in Urothelial Carcinoma

Phase 2 Unknown

Carcinoma, Transitional Cell